Cdc34CRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。Cdc34遺伝子サイレンサーは、Cdc34 CRISPR/Cas9ノックアウトプラスミドとCdc34Double Nickaseプラスミドとして利用可能です。遺伝子活性化用のCdc34CRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
Cdc34 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
Cdc34 CRISPR/Cas9 KOプラスミド (h) | sc-403783 | h | Gene Knockout | GFP | 0 | ||
Cdc34 HDRプラスミド (h) | sc-403783-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Cdc34 Double Nickaseプラスミド (h) | sc-403783-NIC | h | Gene Knockout | Puromycin | 0 | ||
Cdc34 Double Nickaseプラスミド (h2) | sc-403783-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Cdc34 CRISPR/Cas9 KOプラスミド (m) | sc-432058 | m | Gene Knockout | GFP | 0 | ||
Cdc34 HDRプラスミド (m) | sc-432058-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Cdc34 Double Nickaseプラスミド (m) | sc-432058-NIC | m | Gene Knockout | Puromycin | 0 | ||
Cdc34 Double Nickaseプラスミド (m2) | sc-432058-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Cdc34B CRISPR/Cas9 KOプラスミド (h) | sc-409280 | h | Gene Knockout | GFP | 0 | ||
Cdc34B HDRプラスミド (h) | sc-409280-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Cdc34B Double Nickaseプラスミド (h) | sc-409280-NIC | h | Gene Knockout | Puromycin | 0 | ||
Cdc34B Double Nickaseプラスミド (h2) | sc-409280-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Cdc34B CRISPR/Cas9 KOプラスミド (m) | sc-426654 | m | Gene Knockout | GFP | 0 | ||
Cdc34B HDRプラスミド (m) | sc-426654-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Cdc34B Double Nickaseプラスミド (m) | sc-426654-NIC | m | Gene Knockout | Puromycin | 0 | ||
Cdc34B Double Nickaseプラスミド (m2) | sc-426654-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Cdc34 CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
Cdc34 CRISPR Activationプラスミド (h) | sc-403783-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34 CRISPR Activationプラスミド (h2) | sc-403783-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34 Lentiviral Activation Particles (h) | sc-403783-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34 Lentiviral Activation Particles (h2) | sc-403783-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34 CRISPR Activationプラスミド (m) | sc-432058-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34 CRISPR Activationプラスミド (m2) | sc-432058-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34 Lentiviral Activation Particles (m) | sc-432058-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34 Lentiviral Activation Particles (m2) | sc-432058-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34B CRISPR Activationプラスミド (h) | sc-409280-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34B CRISPR Activationプラスミド (h2) | sc-409280-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34B Lentiviral Activation Particles (h) | sc-409280-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34B Lentiviral Activation Particles (h2) | sc-409280-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34B CRISPR Activationプラスミド (m) | sc-426654-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34B CRISPR Activationプラスミド (m2) | sc-426654-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34B Lentiviral Activation Particles (m) | sc-426654-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Cdc34B Lentiviral Activation Particles (m2) | sc-426654-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |